Modified Lipoprotein-Derived Lipid Particles Accumulate in Human Stenotic Aortic Valves

Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation

(2012) Isabel Gonçalves et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Recognition of Porphyromonas gingivalis Gingipain Epitopes by Natural IgM Binding to Malondialdehyde Modified Low-Density Lipoprotein

(2012) S. Pauliina Turunen et al.   PLoS One

Mechanisms of Resolution of Inflammation

(2011) Benjamin H. Maskrey et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification

(2011) Jaakko I. Lommi et al.   ATHEROSCLEROSIS

Calcific Aortic Valve Disease: Not Simply a Degenerative Process

(2011) Nalini M. Rajamannan et al.   CIRCULATION

Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a

(2011) Marja Veneskoski et al.   FREE RADICAL BIOLOGY AND MEDICINE

Lipid body formation during maturation of human mast cells

(2011) Andrea Dichlberger et al.   JOURNAL OF LIPID RESEARCH

Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis

(2011) P. Fogelstrand et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells

(2010) Kasey C. Vickers et al.   ATHEROSCLEROSIS

Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2group V and secretory sphingomyelinase

(2010) Riia Plihtari et al.   JOURNAL OF LIPID RESEARCH

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

(2010) Peter Duewell et al.   NATURE

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

(2010) Kristiina Rajamäki et al.   PLoS One

Lipid Lowering in Aortic Stenosis

(2009) Satu Helske et al.   CIRCULATION

Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice

(2009) Jordan D. Miller et al.   CIRCULATION

Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valve

(2008) Elizabeth H. Stephens et al.   Acta Biomaterialia

Calcific Aortic Stenosis

(2008) Nalini M. Rajamannan   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

(2008) Robert O. Bonow et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

(2008) Anne B. Rossebø et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis

(2007) Dania Mohty et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY